Zealand and Roche are jointly developing the drug petrelintide which in a mid-stage study led to a worse-than-expected 10.7% ...

Vertex Pharmaceuticals Inc VRTX shares are rising in extended trading Monday after the company announced positive interim results for one of its Phase 3 trials. Vertex Pharmaceuticals stock is trading ...

Check out some of the companies making the biggest midday moves: Oil stocks — Oil stocks briefly traded higher as the ...

Xenon Pharmaceuticals Inc. XENE shares are up during Monday’s premarket session following the announcement of positive ...

Helus Pharma HELP shares are down on Thursday following the announcement of topline results from a Phase 2 signal detection study for HLP004, a potential treatment for generalized anxiety disorder ...

The company's pipeline features almost 40 programs in late-stage clinical testing. These clinical trials are testing new drug candidates and seeking additional approvals for drugs such as Tremfya.

Building a big nest egg for your post-work life by buying stocks is very possible, but it requires patience, investing in the ...

Having successfully navigated the Humira patent cliff, AbbVie is poised for continued growth.

In 2024, the pharmaceutical sector in the United States was valued at $634.32 billion, and by 2030, it is expected to have grown to $883.97 billion.

Artificial intelligence (AI) is all the rage on Wall Street these days, but not every AI stock is equally successful. Some of ...